Skip to main content
. 2022 May 22;187(3):353–363. doi: 10.1111/bjd.21595

Table 5.

Infections among the general population and patients with severe psoriasis

IR per 100 000 person‐years among the general population (95% CI) IR per 100 000 person‐years among patients with severe psoriasis (95% CI) IR differences per 100 000 person‐years (95% CI)
Any infections (rare or severe) 2351·9 (2322·9–2381·2) 3847·7 (3754·3–3943·4) 1495·8 (1431·4–1562·2)
Severe infections
Any severe infections 2335·0 (2306·1–2364·1) 3824·6 (3731·6–3919·9) 1489·6 (1425·5–1555·8)
CNS infections 22·03 (19·53–24·84) 40·32 (32·47–50·06) 18·29 (12·94–25·22)
URTI 137·40 (130·92–144·21) 226·99 (207·11–248·79) 89·59 (76·19–104·6)
Pulmonary infections 732·82 (717·46–748·50) 1248·2 (1199·32–1299·0) 515·3 (481·9–550·5)
Heart infections 34·44 (31·28–37·92) 59·56 (49·84–71·18) 25·12 (18·56–33·26)
GI infections 581·99 (568·30–569·01) 872·69 (832·10–915·25) 290·7 (263·8–346·24)
UTI 445·53 (433·65–457·73) 663·59 (628·63–700·48) 218·1 (194·9–242·8)
Gynaecological infections 40·33 (35·52–45·79) 54·174 (41·49–70·73) 13·84 (5·98–24·94)
Musculoskeletal infections 55·23 (51·19–59·60) 110·88 (97·27–126·39) 55·64 (46·08–66·78)
Skin and subcutaneous tissue infections 342·69 (332·28–353·44) 671·88 (636·41–709·32) 329·19 (304·13–355·88)
Opportunistic infections 88·37 (83·20–93·85) 181·09 (163·46–200·63) 92·72 (80·25–106·8)
Other infections 298·21 (288·56–308·18) 542·26 (510·90–575·56) 244·1 (222·3–267·4)
Sepsis 235·25 (226·72–244·1) 450·33 (421·94–480·63) 215·1 (195·2–236·5)
Rare
Any rare infections 31·45 (28·44–34·79) 55·69 (46·31–66·97) 24·24 (17·87–32·18)
HIV 4·15 (3·15–5·48) 7·86 (4·81–12·82) 3·70 (1·67–7·34)
Hepatitis 20·04 (17·66–22·73) 32·48 (25·52–41·34) 12·44 (7·86–18·61)
Tuberculosis 7·56 (6·15–9·28) 15·72 (11·11–22·22) 8·16 (4·96–12·94)

CI, confidence interval; CNS, central nervous system; GI, gastrointestinal; IR, incidence rate; URTI, upper respiratory tract infections; UTI, urinary tract infections.